Early cancer drug trial halted after initial safety testing
NCT ID NCT04272034
Summary
This early-stage study tested a new drug called INCB099318 in people with advanced solid tumors that had stopped responding to standard treatments. The main goal was to check the drug's safety, how the body processes it, and what side effects it might cause. The trial was terminated early, and it involved 105 participants with various advanced cancers who had no other good treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Docrates Cancer Center
Helsinki, 00180, Finland
-
Freeman Hospital Newcastle Upon Tyne Foundation Nhs Trust
Newcastle upon Tyne, NE7 7DN, United Kingdom
-
Ghent University Hospital
Ghent, 09000, Belgium
-
Guys and St Thomas Nhs Foundation Trust
London, SE1 9RT, United Kingdom
-
Hackensack University Medical Center
Hackensack, New Jersey, 07601, United States
-
Haukeland University Hospital
Bergen, 05051, Norway
-
Helsinki University Central Hospital
Helsinki, 00029, Finland
-
Imperial College Healthcare Nhs Trust - Hammersmith Hospital
London, W12 0HS, United Kingdom
-
Institut Jules Bordet
Brussels, B-1070, Belgium
-
Karolinska University Hospital Solna
Solna, 17164, Sweden
-
Oslo University Hospital
Oslo, 00450, Norway
-
Prisma Health Cancer Institute Faris
Greenville, South Carolina, 29605, United States
-
Rigshospitalet Uni of Hospital of Copenhagen
Copenhagen, 02100, Denmark
-
Sahlgrenska University Hospital
Gothenburg, 41345, Sweden
-
St James University Hospital
Leeds, LS9 7TF, United Kingdom
-
Tampere University Hospital
Tampere, 33520, Finland
-
The Royal Marsden Hospital Nhs Trust London
London, SM2 5PT, United Kingdom
-
Turku University Hospital
Turku, 20520, Finland
-
Universitair Ziekenhuis Antwerpen (Uza)
Edegem, 02650, Belgium
-
Universitair Ziekenhuis Brussel
Brussels, 01090, Belgium
-
Universitaire Ziekenhuis Leuven - Gasthuisberg
Leuven, 03000, Belgium
-
Uppsala Universitet - Akademiska Sjukhuset
Uppsala, 75185, Sweden
-
Vanderbilt-Ingram Cancer Center
Nashville, Tennessee, 37232, United States
-
Western General Hospital
Edinburgh, EH4 2XU, United Kingdom
Conditions
Explore the condition pages connected to this study.